Limaye, S. A., Haddad, R. I., Cilli, F., Sonis, S. T., Colevas, A. D., Brennan, M. T., . . . Murphy, B. A. (2013). Phase 1b, multicenter, single blinded, placebo‐controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy. Cancer, 119(24), 4268-4276. https://doi.org/10.1002/cncr.28365
Citace podle Chicago (17th ed.)Limaye, Sewanti Atul, Robert I. Haddad, Fiona Cilli, Stephen T. Sonis, A. Dimitrios Colevas, Michael T. Brennan, Kenneth S. Hu, a Barbara A. Murphy. "Phase 1b, Multicenter, Single Blinded, Placebo‐controlled, Sequential Dose Escalation Study to Assess the Safety and Tolerability of Topically Applied AG013 in Subjects with Locally Advanced Head and Neck Cancer Receiving Induction Chemotherapy." Cancer 119, no. 24 (2013): 4268-4276. https://doi.org/10.1002/cncr.28365.
Citace podle MLA (9th ed.)Limaye, Sewanti Atul, et al. "Phase 1b, Multicenter, Single Blinded, Placebo‐controlled, Sequential Dose Escalation Study to Assess the Safety and Tolerability of Topically Applied AG013 in Subjects with Locally Advanced Head and Neck Cancer Receiving Induction Chemotherapy." Cancer, vol. 119, no. 24, 2013, pp. 4268-4276, https://doi.org/10.1002/cncr.28365.